Thus, in NAFLD data is conflicting whether or not hepcidin predominantly correlates to body iron stores [16, 17], to features of the metabolic syndrome [18, 19] or the hepatic inflammation seen in steatohepatitis (NASH). Here, HAMP is linked to metabolic dysfunction-associated steatohepatitis.